Inpharma Weekly

, Volume 1007, Issue 1, pp 3–4 | Cite as

Lexipafant - a glimmer of hope for pancreatitis

  • Tamara Schwarz
Newsletter Article


The platelet-activating factor (PAF) antagonist lexipafant has a role in the treatment of acute pancreatitis, according to research findings presented at the 5th International Congress on Platelet-Activating Factor and Related Lipid Mediators [ Berlin, Germany; September 1995 ]. The therapeutic potential of PAF antagonists is currently under investigation in several indications, particularly inflammatory diseases. Few convincing findings on the therapeutic value of these agents have been presented to date, but the latest data are encouraging.


Pancreatitis Acute Pancreatitis Organ Failure Placebo Recipient Severe Acute Pancreatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1995

Authors and Affiliations

  • Tamara Schwarz

There are no affiliations available

Personalised recommendations